Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Classical hematology 1

Conditions

Polycystic Ovary Syndrome 18Carcinoma, Non-Small-Cell Lung 14Colorectal Neoplasms 11Lung Neoplasms 9Recurrence 7Neoplasm Metastasis 5Colonic Neoplasms 5Breast Neoplasms 5Rectal Neoplasms 4Ovarian Neoplasms 4Lymphoma, T-Cell, Peripheral 4Infertility 4Neoplasms 3Lymphoma, T-Cell 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sezary Syndrome 2Papillomavirus Infections 2Mycosis Fungoides 2Meningeal Carcinomatosis 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, B-Cell 2Lymphoma 2Insulin Resistance 2Infertility, Female 2Hyperandrogenism 2Head and Neck Neoplasms 2Diabetes, Gestational 2Carcinoma, Transitional Cell 2Atypical Squamous Cells of the Cervix 2

Interventions

eltrombopag 14romiplostim 7avatrombopag 7Platelet Transfusion 6Cytarabine 6Radiotherapy 4Filgrastim 4Etoposide 4Carboplatin 4oprelvekin 3Tranexamic Acid 3Peripheral Blood Stem Cell Transplantation 3Daunorubicin 3Cyclophosphamide 3Busulfan 3hetrombopag 2fludarabine phosphate 2Tretinoin 2Thrombopoietin 2Lenalidomide 2Interleukin-11 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Doxorubicin 2Cyclosporine 2Amplified Fragment Length Polymorphism Analysis 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2sodium thiosulfate 1siltuximab 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × Folic Acid × Clear all
NCT02679443 2017-04-25

PEMVITASTART

Post Graduate Institute of Medical Education and Research, Chandigarh

Phase NA Completed
161 enrolled
Classical hematologyThoracic

Adenocarcinoma of Lung, Cytopenia, Anemia, Neutropenia, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡